Literature DB >> 28713031

An LC-MS/MS based candidate reference method for the quantification of carbamazepine in human serum.

Judith Taibon1, Rupert Schmid2, Stephanie Lucha2, Stephan Pongratz2, Kirill Tarasov2, Christoph Seger3, Christian Timm3, Roland Thiele2, Joachim Mark Herlan2, Uwe Kobold2.   

Abstract

A validated LC-MS/MS-based candidate reference measurement procedure for the quantification of carbamazepine is presented in order to be used for standardization and harmonization of routine assays applied for therapeutic drug monitoring. Sample preparation was based on protein precipitation using acetonitrile followed by sample dilution. Since the previously listed certified reference material (CRM) SRM 1599 (anticonvulsant drug level assay standard) is no longer available, an ISO certified calibration material was used in this assay. As internal standards deuterated analyte congeners were applied. The method allows the measurement of carbamazepine, carbamazepine-10,11-epoxide and 10-hydroxy-10,11-dihydrocarbamazepine in the concentration range of 0.1 to 22.0μg/ml with LODs and LOQs of <0.1μg/ml and 0.1μg/ml, respectively. Comparative measurement of 105 native patient samples using the here presented method showed a good agreement between two independent laboratories with a mean bias of 0.6%.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carbamazepine; Human serum; LC-MS/MS; Metabolites; Reference measurement procedure

Mesh:

Substances:

Year:  2017        PMID: 28713031     DOI: 10.1016/j.cca.2017.07.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Urinary Metabolomics Study of Patients with Gout Using Gas Chromatography-Mass Spectrometry.

Authors:  Qianqian Li; Shuangshuang Wei; Dehong Wu; Chengping Wen; Jia Zhou
Journal:  Biomed Res Int       Date:  2018-10-16       Impact factor: 3.411

2.  Appraisal of the greenness profile of a chromatographic method for the simultaneous estimation of carbamazepine and oxcarbazepine, along with two potential impurities and three formulation excipients.

Authors:  Nada S Abdelwahab; Maha M Abdelrahman
Journal:  RSC Adv       Date:  2021-02-17       Impact factor: 3.361

3.  LC-MS3 Strategy for Quantification of Carbamazepine in Human Plasma and Its Application in Therapeutic Drug Monitoring.

Authors:  Dongxiao Ma; Zhengchao Ji; Haiwei Cao; Jing Huang; Lei Zeng; Lei Yin
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

4.  Development of magnetic molecularly imprinted polymers with double templates for the rapid and selective determination of carbamazepine and lamotrigine in serum.

Authors:  Ya-Qin Wei; Lin-Lin Zhao; Yu-Xin You; Yan-Lin Zhao; Xiao-Xiao Zheng; Yan Du; Dao-Quan Tang
Journal:  RSC Adv       Date:  2022-03-30       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.